Acute coronary syndrome remodels the protein cargo and functions of high-density lipoprotein subfractions

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Tan, Ying ^a   Liu, Ting Rong ^a   Hu, Shui Wang ^a   Tian, Di ^a   Li, Chen ^a   Zhong, Jian Kai ^a   Sun, Hai Ge ^a   Luo, Tian Tian ^a   Lai, Wen Yan ^a   Guo, Zhi Gang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CARGO PROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 3; LIPID HYDROPEROXIDE; PROTEIN; RAB 7B PROTEIN; RAB PROTEIN; UNCLASSIFIED DRUG; HIGH DENSITY LIPOPROTEIN; RAB7 PROTEIN; SERUM AMYLOID P;

ACUTE CORONARY SYNDROME; ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEOMICS; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED;

ACUTE CORONARY SYNDROME; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PROTEOMICS; RAB GTP-BINDING PROTEINS; SERUM AMYLOID P-COMPONENT;

EID: 84899671387     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094264     Document Type: Article

References (38)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, et al. (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8-15. (Pubitemid 19043669)
2. Duffy D, Rader DJ (2009) Update on strategies to increase HDL quantity and function. Nature Reviews Cardiology 6:455-63.
3. Rader DJ (2008) Beyond high-density lipoprotein cholesterol levelsevaluating high-density lipoprotein function as influenced by novel therapeutic approaches. Journal of the American College of Cardiology 51:2199-211. (Pubitemid 351754991)
4. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, et al. (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. New England Journal of Medicine 364:127-35.
5. Guo ZG, Li C, Zhong JK, Tu Y, Xie D (2012) Laboratory investigation of dysfunctional HDL. Chemistry and Physics of Lipids 165:32-7.
6. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, et al. (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. Journal of Clinical Investigation 117:746-56. (Pubitemid 46348533)
7. McGillicuddy FC, de la Llera Moya M, Hinkle CC, Joshi MR, Chiquoine EH, et al. (2009) Inflammation impairs reverse cholesterol transport in vivo. Circulation 119:1135-45.
8. Lehrke M, Millington SC, Lefterova M, Cumaranatunge RG, Szapary P, et al. (2007) CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. Journal of the American College of Cardiology 49:442-9. (Pubitemid 46135882)
9. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, et al. (2006) Mechanisms of disease: proatherogenic HDL-an evolving field. Nature Reviews Endocrinology 2:504-11. (Pubitemid 44353291)
10. Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM (1993) Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
11. Navab M, Ruchala P, Waring AJ, Lehrer RI, Hama S, et al. (2009) A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. Journal of lipid research 50:1538-47.
12. Watson CE, Weissbach N, Kjems L, Ayalasomayajula S, Zhang Y, et al. (2011) Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function. Journal of lipid research 52:361-73.
13. Dodani S, Kaur R, Reddy S, Reed GL, Navab M, et al. (2008) Can dysfunctional HDL explain high coronary artery disease risk in South Asians? International journal of cardiology 129:125-32.
14. Charles-Schoeman C, Watanabe J, Lee YY, Furst DE, Amjadi S, et al. (2009) Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis & Rheumatism 60:2870-9.
15. Rezaee F, Casetta B, Levels JHM, Speijer D, Meijers J (2006) Proteomic analysis of high-density lipoprotein. Proteomics 6:721-30. (Pubitemid 43208050)
16. Davidson WS, Silva RGD, Chantepie S, Lagor WR, Chapman MJ, et al. (2009) Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters relevance to antioxidative function. Arteriosclerosis, thrombosis, and vascular biology 29:870-6.
17. Karlsson H, Leanderson P, Tagesson C, Lindahl M (2005) Lipoproteomics II: Mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5:1431-45.
18. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, et al. (2003) Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108:2751-6. (Pubitemid 37498976)
19. Berrougui H, Isabelle M, Cloutier M, Grenier G, Khalil A (2007) Age-related impairment of HDL-mediated cholesterol efflux. Journal of lipid research 48:328-36. (Pubitemid 46220599)
20. Beltowski J, Jamroz-Wisniewska A, Borkowska E, Wójcicka G (2005) Differential effect of antioxidant treatment on plasma and tissue paraoxonase activity in hyperleptinemic rats. Pharmacol Res 51:523-532.
21. Arab K, Steghens JP (2004) Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 325(1):158-63. (Pubitemid 38050279)
22. Julia Z, Duchene E, Fournier N, Bellanger N, Chapman MJ, et al. (2010) Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia. Journal of lipid research 51:3350-8.
23. Shao B, Oda MN, Oram JF, Heinecke JW (2006) Myeloperoxidase: An inflammatory enzyme for generating dysfunctional high density lipoprotein. Current opinion in cardiology 21:322-8. (Pubitemid 44315065)
24. Alwaili K, Bailey D, Awan Z, Bailey SD, Ruel I, et al. (2012) The HDL proteome in acute coronary syndromes shifts to an inflammatory profile. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 1821:405-15.
25. Filippo CD, Cuzzocrea S, Rossi F, Marfella R, D'Amico M (2006) Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovascular drug reviews 24:77-87. (Pubitemid 46696918)
26. Ostos MA, Conconi M, Vergnes L, Baroukh N, Ribalta J, et al. (2001) Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E-Deficient Mice. Arteriosclerosis, thrombosis, and vascular biology 21:1023-8. (Pubitemid 34168663)
27. Lin C-Y, Duan H, Mazzone T (1999) Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. Journal of lipid research 40:1618-26. (Pubitemid 29418702)
28. Rader DJ (2006) Molecular regulation of HDL metabolism and function: implications for novel therapies. Journal of Clinical Investigation 116:3090-100. (Pubitemid 44878620)
29. Previsdomini M, Stocker R, Corti R, Cerutti B, Perren A (2007) Time course of hemoglobin concentrations in the intensive care unit in nonbleeding patients with acute coronary syndrome. The American journal of cardiology 100:579- 82. (Pubitemid 47223131)
30. Watanabe J, Grijalva V, Hama S, Barbour K, Berger FG, et al. (2009) Hemoglobin and its scavenger protein haptoglobin associate with apoA-1- containing particles and influence the inflammatory properties and function of high density lipoprotein. Journal of Biological Chemistry 284:18292-301.
31. Nabais S, Gaspar A, Costa J, Azevedo P, Rocha S, et al. (2009) Prognostic impact of hemoglobin drop during hospital stay in patients with acute coronary syndromes.
32. Nagy E, Eaton JW, Jeney V, Soares MP, Varga Z, et al. (2009) Red cells, hemoglobin, heme, iron, and atherogenesis. Arteriosclerosis, thrombosis, and vascular biology 30:1347-53.
33. Ortiz-Munoz G, Houard X, Martín-Ventura J-L, Ishida BY, Loyau S, et al. (2009) HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property. The FASEB Journal 23:3129-39.
34. Song Z, Cai L, Guo L, Tsukamoto Y, Yutani C, et al. (2010) Accumulation and expression of serum amyloid P component in human atherosclerotic lesions. Atherosclerosis 211:90-5.
35. Li X-A, Yutani C, Shimokado K (1998) Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein. Biochemical and biophysical research communications 244:249-52. (Pubitemid 28419933)
36. Stewart CR, Tseng AA, Mok Y-F, Staples MK, Schiesser CH, et al. (2005) Oxidation of low-density lipoproteins induces amyloid-like structures that are recognized by macrophages. Biochemistry 44:9108-16. (Pubitemid 40943225)
37. Yao M, Liu X, Li D, Chen T, Cai Z, et al. (2009) Late endosome/lysosomelocalized Rab7b suppresses TLR9-initiated proinflammatory cytokine and type I IFN production in macrophages. The Journal of Immunology 183:1751-8.
38. Yamamoto N, Homma S, Millman I (1991) Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. The Journal of Immunology 147:273-80.